The Influence of Quinolines on Coumarin 7-Hydroxylation in Bovine Liver Microsomes and Human CYP2A6.
- 1 January 2002
- journal article
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 48 (2) , 118-125
- https://doi.org/10.1248/jhs.48.118
Abstract
Quinoline is a chemical with potential pharmaceutical components, such as antimalaria, antiulcer, and antibiotic agents. Quinoline is metabolized by CYP2A6, whose activity is generally shown by coumarin 7-hydroxylation, and the principal product is the 5,6-epoxide of quinoline. We found coumarin 7-hydroxylase activity in bovine liver microsomes and studied the interaction of quinoline and some quinoline derivatives with coumarin 7-hydroxylase activity by fluorometry. Quinoline inhibited coumarin metabolism, and the apparent Vmax value decreased to 0.39 nmol/min/nmol cytochrome P-450 (CYP) in the presence of quinoline from the value (Vmax = 0.63 nmol/min/nmol CYP) in the absence of quinoline. 5-fluoroquinoline (5FQ), 6-fluoroquinoline (6FQ) and 8-fluoroquinoline (8FQ) showed stronger inhibition than quinoline, whereas 3-fluoroquinoline (3FQ) showed weaker inhibition (apparent Vmax was 0.59 nmol/min/nmol CYP). Almost the same inhibition pattern of fluoroquinolines were found in assays of cDNA-expressed human CYP2A6. The results suggest that bovine CYP2A enzymes (s) as well as human CYP2A6 can interact strongly with monofluoroquinolines such as 5-, 6-, and 8-FQ, but weakly with 3-FQ.Keywords
This publication has 21 references indexed in Scilit:
- PREDICTING DRUG INTERACTIONS AND PHARMACOKINETIC VARIABILITY WITH IN VITRO METHODS: THE OLANZAPINE EXPERIENCE1*Drug Metabolism Reviews, 1999
- The P450 Catalytic Cycle and Oxygenation MechanismDrug Metabolism Reviews, 1998
- Cytochrome P450 species involved in the metabolism of quinolineCarcinogenesis: Integrative Cancer Research, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- A tobacco smoke-derived nitrosamine, 4-(methytnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytocbrome P450s including the polymorphic human cytochrome P4502D6Carcinogenesis: Integrative Cancer Research, 1991
- Effect of inducers of cytochrome P-450 on the metabolism of [3-14C]coumarin by rat hepatic microsomesXenobiotica, 1991
- Deprivation of the mutagenic property of quinoline. Inhibition of mutagenic metabolism by fluorine substitution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
- Purification and properties of bovine liver seryl-tRNA synthetaseEuropean Journal of Biochemistry, 1984
- Metabolites of quinoline, a hepatocarcinogen, in a subcellular microsomal system.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Seryl-tRNA synthetase and activation of the carcinogen 4-nitroquinoline 1-oxideNature, 1975